Barclays analyst Matt Miksic maintained a Buy rating on Baxter International (BAX – Research Report) on March 7 and set a price target of ...

Clinical teams working in hospitals are constantly on the move, keeping up with urgent demands in a fast-paced environment. | ...

Baxter International shares surged Thursday after the medical device maker's fourth-quarter results topped estimates.

Baxter International Inc. closed 20.10% short of its 52-week high of $44.01, which the company reached on March 8th.

Three decades after its original premiere, William Kentridge and the renowned Handspring Puppet Company reunite to bring ...

Barclays raised the firm’s price target on Baxter (BAX) to $41 from $39 and keeps an Overweight rating on the shares. The firm updated its ...

Story Continues Top-line performance in the fourth quarter exceeded Baxter’s previously announced guidance, driven by better-than-expected sales in the company’s Medical Products & Therapies ...

Blaming a Biden-era federal agency is an easy public-relations sell in deeply red Baxter County. It is almost certainly ...

Top-line performance in the fourth quarter exceeded Baxter’s previously announced guidance, driven by better-than-expected sales in the company’s Medical Products & Therapies and ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Baxter reported Q4 adjusted EPS of $0.58 ... Get the latest picks today before they gain traction. The medical device company reported sales of $2.75 billion, up 1% year over year (+2% on a ...